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AbstrAct
background and aims Microbiota alterations are 
linked with colorectal cancer (CRC) and notably higher 
abundance of putative oral bacteria on colonic tumours. 
However, it is not known if colonic mucosa-associated 
taxa are indeed orally derived, if such cases are a distinct 
subset of patients or if the oral microbiome is generally 
suitable for screening for CRC.
Methods We profiled the microbiota in oral swabs, 
colonic mucosae and stool from individuals with CRC (99 
subjects), colorectal polyps (32) or controls (103).
results Several oral taxa were differentially 
abundant in CRC compared with controls, for example, 
Streptococcus and Prevotellas pp. A classification model 
of oral swab microbiota distinguished individuals with 
CRC or polyps from controls (sensitivity: 53% (CRC)/67% 
(polyps); specificity: 96%). Combining the data from 
faecal microbiota and oral swab microbiota increased the 
sensitivity of this model to 76% (CRC)/88% (polyps). We 
detected similar bacterial networks in colonic microbiota 
and oral microbiota datasets comprising putative oral 
biofilm forming bacteria. While these taxa were more 
abundant in CRC, core networks between pathogenic, 
CRC-associated oral bacteria such as Peptostreptococcus, 
Parvimonas and Fusobacterium were also detected in 
healthy controls. High abundance of Lachnospiraceae 
was negatively associated with the colonisation 
of colonic tissue with oral-like bacterial networks 
suggesting a protective role for certain microbiota 
types against CRC, possibly by conferring colonisation 
resistance to CRC-associated oral taxa and possibly 
mediated through habitual diet.
conclusion The heterogeneity of CRC may relate 
to microbiota types that either predispose or provide 
resistance to the disease, and profiling the oral 
microbiome may offer an alternative screen for detecting 
CRC.
IntroductIon
Microbes have been implicated in the pathogenesis 
of several human cancers, most strikingly in the 
case of Helicobacter pylori and gastric carcinoma 
and some gastric lymphomas.1 2 H. pylori is now 
designated a gastric carcinogen and a preclinical risk 
factor. Current non-invasive screening approaches 
for colon cancer such as faecal immune test (FIT) 
and faecal occult blood test (FOBT) have very low 
sensitivity for detecting early lesions, and more reli-
able biomarkers are required. We and others have 
reported changes in the faecal or colonic mucosal 
microbiota in patients with colorectal cancer 
(CRC),3–8 and data from several animal models 
have implicated the microbiota in the pathogenesis 
of CRC.9–13 Our finding of a microbiota configu-
ration associated with benign colonic polyps that 
is intermediate between that of controls and those 
with cancer suggests that the microbiota might 
provide a potential biomarker predictive of the risk 
of later development of cancer. It also suggests that 
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Key messages
What is already known on this subject?
 ► The gut microbiota is associated with colorectal 
cancer (CRC) development.
 ► Faecal microbiota has potential as a biomarker 
for CRC.
 ► Putatively oral bacteria are more abundant on 
CRC biopsies and Fusobacterium nucleatum has 
been reported to be enriched in IBD.
 ► A ‘Western diet’ contributes to CRC 
development.
What are the new findings?
 ► We developed an oral and faecal microbiota-
based classifier that distinguished individuals 
with CRC and adenomas from healthy controls. 
The discriminatory power particularly for 
adenomas was higher than for currently used 
tests.
 ► We detected similar networks of oral bacteria 
at both oral and colonic mucosal surfaces, 
including in individuals with colonic lesions (on 
and off the tumour), healthy controls and 
children with and without Crohn’s disease.
 ► A microbiota rich in Lachnospiraceae was 
negatively correlated with ‘Western diet’ 
and colonic colonisation with oral bacteria, 
including oral pathogens associated with CRC, 
suggesting a protective role, possibly mediated 
through habitual diet.
How might it impact on clinical practice in the 
foreseeable future?
 ► If the suitability of oral microbiota screening for 
the detection of CRC and polyps can be verified 
in larger study groups, this could significantly 
improve current screening programmes.
 Gut Online First, published on October 7, 2017 as 10.1136/gutjnl-2017-314814
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table 1 Clinical data of the studied individuals
sample type samples (n) Age (mean±sd) bMI (mean±sd) Males
tumour size 
(mean±sd)
rectal bleeding 
(%)
Alcohol (1st quantile, 
third quantile) (units/
week) currently smoking (%)
Tissue controls 59 53.2±13.5 27.4±6.1 44.1 NA 57.7 1 (1, 10) 4
Off CRC 74 66±11.3 28.7±5.7 66.7 3.2±1.8 65.6 2 (1, 10) 10.4
Off Polyps 31 61.6±14.8 28.8±5 71 NA 38.7 1 (1, 10) 13.3
On CRC 65 67±11.6 28.8±5.8 60.9 3.6±2 64.4 2 (0.8, 10) 5
On Polyps 2 76.5±0.7 27.4±0.9 100 NA 50 7.5 (4.2, 10.8) 0
Stool controls 62 63.9±11.1 28.2±5.4 50.9 NA 55.6 1 (0.2, 6.2) 0
Stool CRC 69 65.3±10.8 28.4±6.1 66.7 3.1±1.7 65.5 2 (1, 11.2) 11.3
Stool polyp 23 60.4±13.4 29.3±5.4 78.3 NA 39.1 4 (1, 13.5) 17.4
Swab controls 25 51.5±12.4 27.1±5.5 37.5 NA 57.9 1 (1, 6) 0
Swab CRC 45 65.7±10.9 27.1±5 56.1 3.3±1.9 66.7 2 (1, 9) 0
Swab polyp 21 59.2±15.1 28.5±5.2 71.4 NA 38.1 1 (1, 10) 10
BMI, body mass index; CRC, colorectal cancer.
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an intervention could theoretically be applicable years before the 
development of the disease. The additional finding by us and 
others of microbes that are normally associated with the oral 
cavity3–8 13 being present in the faecal and mucosal microbiota 
linked with CRC prompted us to investigate the oral microbiota 
in colon cancer as a first step in determining if it might serve as 
a more accessible sampling site for convenient and widespread 
screening. Previously, several groups reported the applicability of 
faecal microbiota profiling as a tool for detection of CRCs,4 5 14 
particularly in conjunction with the FOBT5 or FIT.4 Moreover, 
distinct bacterial profiles in the oral cavity have been associ-
ated with oral cancers15 16 and with esophageal17 and pancreatic 
cancers.18 19 A single study identified significant differences in 
the bacteria present in oral rinse samples from individuals with 
CRC compared with healthy controls.20
Here, we present the findings of an extended CRC study 
population and include an assessment of the oral microbiota. We 
developed a classifier using oral and faecal microbiota profiles 
with high specificity and sensitivity particularly for the detection 
of colorectal polyps. Furthermore, we found similar bacterial 
networks at both oral and colonic mucosal surfaces that were 
enriched in CRC and also detectable in healthy tissue. However, 
we could not find a direct link between oral and colonic micro-
biota such that elevated abundance of bacteria in the oral cavity 
was predictive of colonic colonisation by the same taxa. Rather, 
colonic presence and abundance of oral pathogens was nega-
tively associated with the colonic abundance of Lachnospiraceae. 
We also detected weak negative correlations of Lachnospiraceae 
with dietary habits reminiscent of a ‘Western diet’. Lastly, in a 
meta analysis, we found similar networks of oral bacteria to be 
enriched in colonic tissue of children in a recent Crohn’s disease 
study. Thus, our data indicate that oral bacterial networks found 
in the colon already establish at an early age and before disease 
can be detected. Lachnospiraceae may protect against colonisa-
tion with oral bacteria, possibly mediated through dietary habits. 
Colonic oral bacterial overgrowth is not unique to CRC but 
associated with Crohn’s disease.
MAterIAls And MetHods
sampling, dnA extraction and 16s rrnA gene amplicon 
sequencing
Faecal samples were self-collected and sent to the laboratory 
within 1 hour of defecation. Tissue samples were either collected 
during colorectal surgery or colonoscopy. Oral samples were 
obtained by rubbing the inside of both cheeks with a swab. 
Exclusion criteria were a personal history of CRC, IBD and irri-
table bowel syndrome. A breakdown of the analysed samples 
is given in table 1. Detailed demographic information for each 
individual is given in (online supplementary table 1).
Genomic DNA was extracted using the AllPrep DNA/RNA 
kit from Qiagen (Hilden, Germany). 16S rRNA gene ampl-
icon sequencing libraries of the V3-V4 region were prepared, 
and pools of amplicons were sequenced at GATC (Konstanz, 
Germany) on a MiSeq sequencing instrument (Illumina, San 
Diego, California, USA) using 2×250 bp chemistry.
16S amplicon sequences from our Irish cohort were processed 
as previously described.3 We also conducted a meta-analysis 
with amplicon sequencing data pertaining to Gevers et al21 and 
processed data associated with this study similarly. In order to 
compare bacterial operational taxonomic units (OTUs) obtained 
in the Irish CRC cohort (sequenced region: V3-V4) with OTUs 
obtained in the Crohn’s disease cohort (V4), we shortened the 
sequences of the CRC cohort to the sequenced region of the CD 
cohort using cutadapt,22 and then processed the sequences of the 
two studies together.
Statistical analysis was carried out in R.23
A more detailed description of the employed protocols is 
available as (online supplementary information).
crc classifier
The Random forest (RF) classifier to determine OTUs suitable as 
biomarkers of colonic lesions was described elsewhere.4 In brief, 
we used log-ratio transformed values of OTUs present in at least 
5% of individuals as input to the function AUCRF of the AUCRF 
package.24 Significance of difference between ROC curves was 
assessed using the function  roc. test of the pROC package.25 A 
schematic is depicted in online supplementary figure 1. We also 
employed an in-house pipeline for classification that consisted of 
a two-step procedure: the least absolute shrinkage and selection 
operator (LASSO) feature selection, followed by RF modelling. 
The full dataset was preprocessed (ie, filtered to exclude features 
that were present in less than 5% of individuals). Ten-fold 
cross-validation (CV) was applied to the data. Within each iter-
ation of the 10-fold CV, feature selection was performed using 
the LASSO algorithm on 90% of the dataset, which was used as a 
training set to generate a predictive model within each iteration. 
LASSO improves accuracy and interpretability of models by effi-
ciently selecting the relevant features, a process which is tuned 
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Figure 1 The oral microbiota of individuals with CRC is statistically 
significantly different from that of healthy individuals. Shown is the 
PCoA of the unweighted UniFrac distance (significance assessed using 
PERMANOVA as described in Materials and Methods). CRC, colorectal 
cancer; PERMANOVA, permutational analysis of variance.
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by the parameter lambda. The model was generated within the 
10-fold CV training data by filtering the dataset to include only 
the features selected by the LASSO algorithm, and RF was used 
for subsequent modelling of this subset. Both LASSO feature 
selection and RF modelling were performed within the 10-fold 
CV, which generates an internally validated list of features and 
an internal 10-fold prediction in order to generate an estimate 
of the predictive value of the overall model. We report both the 
results from the default threshold selected by the model and an 
Youden optimised result where the threshold has been optimised 
to improve the sensitivity and specificity. A schematic for this 
protocol is presented in online supplementary figure 2).
results
the oral microbiota is significantly different in crc
We analysed the microbiota from individuals with CRC, 
colorectal polyps and healthy controls from multiple body sites 
(table 1) using 16S rRNA gene amplicon sequencing. The 10 
most abundant bacterial genera across all oral swab samples 
were Streptococcus (30.7% of all assigned reads), Haemophilus 
(14.2%), Neisseria (8.8%), Prevotella (6.6%), Fusobacterium 
(5.4%), Veillonella (5.4%), Leptotrichia (3.9%), Rothia (3.9%), 
Actinomyces (2.9%) and Porphyromonas (2.4%) (online supple-
mentary table 2). These proportional abundance values are 
similar to those reported in previous studies of the microbiota 
associated with the oral cavity.26 27
Microbiota profiling by sequencing identifies bacterial taxa as 
sequence-based divisions or OTUs. The overall oral profile of 
bacterial OTUs (grouped at 97% sequence similarity) was signifi-
cantly different between individuals with CRC and healthy 
controls (permutational analysis of variance of the unweighted 
UniFrac distance, figure 1). Moreover, eight oral microbiota 
OTUs were differentially abundant between individuals with 
CRC and healthy controls (ANCOM, FDR<0.05). Differentially 
abundant OTUs were classified as Haemophilus, Parvimonas, 
Prevotella, Alloprevotella, Lachnoanaerobaculum, Neisseria and 
Streptococcus (online supplementary table 2). Almost all differ-
entially abundant OTUs (7/8) were less abundant in individuals 
with CRC than in healthy individuals. Even though the overall 
microbiota was similar between individuals with polyps and 
healthy controls, four individual bacterial OTUs were differen-
tially abundant between the two groups (online supplementary 
table 2), three of which were also differentially abundant in 
CRC.
oral and stool microbiota as biomarkers of crc
Current non-invasive screening tools for CRC can reliably 
detect advanced carcinomas based on traces of blood in faeces 
released by colonic lesions, but these methods suffer from low 
sensitivity for detecting early lesions.28 Motivated by the find-
ings presented above, we assessed the suitability of oral micro-
biota as a screening tool for identifying subjects with polyps 
and CRC by employing a previously established RF classifica-
tion methodology4 (online supplementary figure 1). The model 
identified 16 oral microbiota OTUs that distinguish individuals 
with CRC from healthy controls. The sensitivity of detection 
was 53% (95% CI (31.11% to 93.33%) with a specificity of 
96% (area under the curve (AUC): 0.9; 95% CI (0.83 to 0.9); 
figure 2 and online supplementary figure 3). The model could 
also be used to detect individuals with colorectal polyps based 
on the abundance of 12 oral OTUs (sensitivity 67%; 95% CI 
(23.81% to 90.48%); AUC: 0.89; 95% CI (0.8 to 0.89); figure 2 
and online supplementary figure 4). Our findings are also consis-
tent with previous reports4 5 in that faecal microbiota abundance 
of selected OTUs is able to distinguish individuals with CRC 
or polyps from healthy persons (figure 2). However, the sensi-
tivity of our model to use faecal microbiota to detect individuals 
with CRCs was considerably lower (sensitivity 22%; 95% CI 
(4.35% to 52.17%); specificity 95%, AUC 0.81; 95% CI (0.73 to 
0.81)) than previously reported. A combination of oral and stool 
microbiota data improved the model sensitivity to 76% (95% 
CI (59.9% to 92%), AUC: 0.94; 95% CI (0.87 to 0.94) for the 
detection of CRCs and 88% for polyps (95% CI (68.75% to 
100%), AUC: 0.98; 95% CI (0.95 to 0.98) for the detection of 
polyps (both: specificity 94% or more) (figure 2). Analysis of the 
abundances of 28 bacterial OTUs were optimal for the differ-
entiation between individuals with polyps and healthy controls 
(for 12 OTUs, the abundance in the oral cavity was used, while 
for 16 OTUs, the faecal abundance was used); the model for the 
detection of CRCs used 63 OTUs (29 oral OTUs and 34 stool 
OTUs).
We were able to confirm the predictive value of the oral 
microbiota for CRC screening by employing an in-house pipe-
line using a LASSO feature selection step and a RF classifier 
within a 10-fold CV pipeline (see online supplementary figure 
2). This methodology, using the default probability threshold 
and when applied to the oral swab microbiota dataset, yielded 
74% sensitivity and 90% specificity (AUC 0.91) for the predic-
tion of adenomas and 98% sensitivity and 70% specificity (AUC 
0.96) for the prediction of CRC, respectively. For a full list of 
values, please see online supplementary table 3.
oral bacteria are abundant in the gut microbiota of 
individuals with crcs and polyps and form similar 
coabundance networks on both oral mucosa and colonic 
tissue
We extended our analysis of oral bacterial networks to the 
gut because we and others have reported the over-abundance 
of putatively oral bacteria on CRCs and polyps.3 5 6 13 These 
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Figure 2 Oral and stool microbiota profiles are potential tools for the detection of CRC. (A and B) Receiver operating characteristic curves (ROC) 
and area under the curve (AUC) values for the prediction of CRC (A) and polyps (B) using microbiota profiles from oral swabs, stool or a combination 
of both. AUC values were highest for the combination test. Significance determined after DeLong (Materials and Methods). Sample numbers: swabs: 
n=25 (healthy controls), n=45 (CRCs), n=21 (polyps); stool: n=62 (healthy controls), n=69 (CRCs), n=23 (polyps); and combination: n=19 (healthy 
controls), n=25 (CRCs), n=16 (polyps). CRC, colorectal cancer; FPR, false-positive rate; TPR, true-positive rate.
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bacteria have also been linked to an inflammatory host response 
and accelerated progression of CRC.3 6 11 29
Our analysis focused on the 17 OTUs that were shared 
between the oral cavity and CRC and polyp samples; that is, 
OTUs that were detected in 37% of both tissue samples and oral 
swabs. As with our previous approach to microbiota analysis 
from cancerous and healthy colon tissue,3 we clustered these 
bacteria based on their abundance profiles in tumour samples 
(figure 3A). The two tumour-associated bacterial coabundance 
groups (CAGs) thus identified comprised (a) oral pathogens 
previously linked with late colonisation of oral biofilms and 
with human diseases including CRC (eg, F. nucleatum, Parvi-
monas micra, Peptostreptococcus stomatis, Dialister pneu-
mosintes and others30–33), designated here as the oral pathogen 
CAG and comprising seven OTUs in total. The second CAG 
comprised dominant bacteria in early dental biofilm formation, 
including Actinomyces, Haemophilus, Rothia, Streptococcus and 
Veilonella spp.,34 genera also associated with relatively healthy 
tooth pockets32 (so-called biofilm CAG; 10 OTUs). Collectively, 
the read counts of OTUs found in the pathogen CAG and the 
biofilm CAG comprised more than 55% of the average number 
of sequence reads from oral mucosal surfaces. Bacteria of these 
two CAGs were significantly more abundant both on and off the 
tumour compared with healthy controls (figure 3B).
Additionally, we analysed oral bacterial networks detected 
across different disease stages and different sample types, 
that is, in (1) oral swabs, (2) in undiseased tissue from individ-
uals with CRC and polyps, (3) in tissue from healthy controls, 
(4) in stool from individuals with CRC and (5) in stool from 
healthy controls. Strikingly, the bacterial networks detected on 
CRC biopsies (figure 3A and figure 4A) were similar in oral 
swabs (figure 4B), undiseased tissue samples from individuals 
with CRC and colonic polyps (figure 4C). Moreover, similar 
networks of bacterial OTUs from the oral cavity were also found 
in tissue samples from healthy individuals (figure 4D), indicating 
that these networks exist prior to the development of CRC and 
could theoretically be involved in the initiation of CRC. These 
networks were only partially detectable in faecal samples from 
individuals with CRC or polyps (figure 4E) and faecal micro-
biota of healthy controls (figure 4F), suggesting tight associa-
tion with the mucosa and highlighting the limitations of faecal 
samples for CRC microbiota detection. Details of the overlap of 
OTUs between the different sample types are presented in the 
Venn diagram in online supplementary figure 5.
low colonic abundance of lachnospiraceae favours 
colonisation of gut mucosa by oral pathogens linked to crc
Given the associations of oral bacteria with the altered 
microbiota found on CRC biopsies and our current finding 
that characterising oral microbiota profiles has potential 
for CRC detection, we hypothesised that the oral micro-
biota might generally be reflected in gut microbiota compo-
sition. However, bacteria typically enriched on colorectal 
tumours and found in both the oral cavity and the colon, 
such as Porphyromonas, Parvimonas and Fusobacterium, 
were less abundant in the oral mucosa of individuals with 
CRC compared with healthy controls (online supplementary 
table 2, statistically significant difference for one Parvimonas 
OTU). Furthermore, the total number of bacteria of the oral 
pathogen CAG (figure 3) detected in the oral cavity was lower 
in CRC (p<0.01; Wilcoxon rank-sum test). Surprisingly, we 
even detected statistically significant negative correlations 
between oral and colonic abundance of OTUs of the oral 
pathogen CAG (figure 3) classified as Dialister (Kendall’s τ
=−0.34, p<0.05, n=65 sample pairs), Peptostreptococcus (τ
=−0.28, p<0.05) and Parvimonas (τ=−0.24, p<0.05).
We then asked whether the overall gut microbiota compo-
sition of a subject, irrespective of having cancer or being a 
healthy control, determines whether oral bacteria become part 
of the gut microbiota. To test this, we first determined bacte-
rial CAGs in this extended dataset for all OTUs (as opposed to 
the analysis shown in figure 3A, which only considers the 17 
OTUs shared between the oral cavity and tumours) at colonic 
lesions (figure 5A) and in colonic mucosa of healthy individuals 
(CAG plot not shown). Similar to our previous analyses,3 OTUs 
with increased relative abundance in CRC were predominantly 
clustered into Bacteroidetes, Prevotella and oral bacterial CAGs, 
whereas OTUs in the Lachnospiraceae CAG were mostly less 
abundant in individuals with CRC (figure 5A). Detailed analysis 
of the correlations between the abundance of bacteria shared 
between the oral cavity and colonic tissue (figure 3) and the abun-
dance of other colonic mucosa-associated bacteria revealed that 
oral pathogen CAG OTUs were strongly negatively correlated 
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Figure 3 Oral bacterial networks are detected in colonic mucosa and are enriched in CRC. (A) Clustering of the 17 oral bacterial OTUs associated 
with tumour tissue into two coabundance groups (CAGs). CAGs were defined on the basis of the clusters in the vertical or horizontal trees and named 
after their most notable characteristic. Column and row bars indicate bacterial CAGs (as per legend to the bottom right) and fold change between 
individuals with CRC and healthy controls (as per legend to the bottom left). Legend top left: colour-scale correlation coefficient. (B) The two CAGs 
comprising typically oral bacteria (oral pathogen CAG and biofilm CAG) were more abundant in colonic microbiota of CRC. Shown are boxplots of 
relative abundances of the two CAGs in colon tissue. n (controls)=59, n (off)=105, n (tumours)=67. CRC, colorectal cancer; FDR, false discovery rate; 
HC, healthy controls; OTUs, operational taxonomic units.
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with Lachnospiraceae CAG OTUs (figure 5A, dark green-co-
loured CAG). More specifically, 125 of the 130 (96%) negative 
correlations (SparCC pseudo-p<0.01) these oral bacterial OTUs 
had with other bacteria were with OTUs of the Lachnospira-
ceae CAG. We next analysed the prevalence of oral bacteria 
on colorectal tumours and found that most bacteria of the oral 
pathogen and biofilm CAGs, while often statistically significantly 
more abundant in CRC (figure 4), only colonised ~40%–70% 
of cancers (figure 5B), a phenomenon also noted by others.29 35 
When we compared the colonic abundance of the other bacterial 
CAGs detected at colorectal lesions (figure 5A) between these 
two groups, prevalence of bacteria of the oral pathogen CAG 
was associated with decreased abundance of the Lachnospiraceae 
CAG in both healthy individuals (p<0.1, Wilcoxon rank-sum 
test) and individuals with colonic lesions (p<0.01). Lastly, we 
detected a negative association between the abundance of the 
Lachnospiraceae CAG and and a ‘Western diet’, even though 
the signal was weak (see online supplementary information for 
details). In summary, our data suggest that colonic establishment 
of a putatively pathogenic oral-like community is more common 
in individuals with CRC and colonic polyps and in individuals 
with a low colonic abundance of Lachnospiraceae, a family of 
butyrate-producing Clostridia already associated with reduced 
risk of colon cancer. Colonisation of the gut by oral bacteria 
associated with CRC may be partially mediated or facilitated by 
consuming a diet high in fat and carbohydrates (typical ‘Western 
Diet’).
orally derived bacteria and non-neoplastic colonic disease
To determine if colonic colonisation with orally derived 
bacteria occurs only in older people and if it occurs in other 
disorders, we included 16S rRNA sequences from a large 
microbiota dataset of >300 children with and without CD21 
into our analysis. To facilitate comparison of the two data-
sets, we reanalysed our sequences from the oral cavity and 
tumour mucosa using only the shared sequence fragment 
(16S rRNA variable region 4) together with the CD data. 
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Figure 4 Bacterial networks detected at colonic mucosal surfaces (panels A,C,D) are similar to those networks detected at oral mucosal surfaces (B) 
and were not or only partially detected in faecal samples (panels E,F). Shown are network plots of bacterial OTUs found in both the oral cavity and 
colonic microbiota in different groups of samples: (A) diseased colorectal tissue (ON; 65 individuals with CRC and 2 polyps), (B) oral swab samples (45 
individuals with CRC, 21 individuals with polyps and 25 healthy controls), (C) undiseased colorectal tissue (off) from 74 individuals with CRC and 31 
individuals with polyps, (D) colorectal tissue from 59 healthy controls, (E) faecal samples from 69 individuals with CRC and 23 individuals with polyps 
and (F) faecal samples from 62 healthy controls. For each group of samples, the OTUs shared with the oral cavity was determined separately. The 
size of each node (OTU) correlates to the mean abundance of each OTU across all samples in each respective sample group. The colour of each node 
corresponds to the CAG determined using diseased colorectal tissue only (figure 3A). One OTU (no. 7, panel C) was only shared between undiseased 
colorectal tissue and the oral cavity, and it is thus coloured grey. The width of each edge corresponds to the p value of the correlation between each 
respective node (lower p value, higher line width). The location of each node was determined by a PCoA of the correlation distance as described in 
Materials and Methods. Only nodes with at least one significant edge are shown. Legend to the right: genus-level classification using RDP reference, 
version 14 of OTU representative sequences. CRC, colorectal cancer; ON, sample from the cancer or polyp; OTUs, operational taxonomic units; PCoA, 
Principal Coordinates Analysis; RDP, Ribosomal Database Project.
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We detected similar relationships of bacteria in both CD and 
CRC, particularly with regards to the Lachnospiraceae, Bacte-
roidetes and Pathogen CAGs (figure 6 and for comparison 
figure 5 and online supplementary figures 3 and 4). However, 
we could not detect a Prevotella CAG in children, which may 
reflect age and/or workflow-associated specifics. Strikingly, 
as in CRC, the pathogen CAG-type microbiota in children 
with CD comprised most of the statistically significantly more 
abundant bacterial OTUs, including OTUs also found in the 
oral cavity (figure 6A, onlinesupplementary figures 6 and 7). 
Detailed comparison of the OTUs found in the oral cavity 
and at colonic mucosal surfaces of individuals with CRC or 
CD revealed that the same OTUs classified as Fusobacterium, 
Haemophilus, Streptococcus, Gemella, Rothia, Actinomyces, 
Granulicatella and Veilonella were detected in both CD and 
CRC, whereas OTUs classified as Peptostreptococcus and 
Parvimonas were only found in CRC (see also figure 6B). 
Some genera found in both CD and CRC contained OTUs that 
were unique to either CD or CRC (eg, the genus Dialister was 
found in both CD and CRC, but the OTUs were different). 
The same oral OTUs were detected in the two diseases, and 
the OTUs were organised in similar networks (figure 6, panels 
C–E). Lastly, similar to CRC, the abundance of oral bacterial 
OTUs was negatively correlated with the abundance of Lach-
nospiraceae CAG OTUs in CD (91% of all negative correla-
tions were with OTUs of the Lachnospiraceae CAG).
dIscussIon
We present for the first time the combined analysis of the micro-
biota of subjects with CRC using samples from the oral cavity, 
colonic mucosal tissue and faeces. We show that profiling the 
bacteria associated with the oral cavity may have value in the 
detection of CRC. Our data also indicate that many bacterial taxa 
found in the oral cavity colonise a subset of colorectal tumours 
and form bacterial coabundance networks similar to those found 
in the oral cavity. These networks seem to form tight associa-
tions with the mucosa, because they are less readily detectable 
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Figure 5 Oral bacterial colonisation of human CRCs is negatively associated with the colonic mucosal abundance of the Lachnospiraceae CAG. (A) 
The relative abundance of oral pathogens at colonic lesions (found mostly in bright red CAG) is negatively correlated with the relative abundance of 
OTUs clustered in a CAG mainly comprising Lachnospiraceae (Lachnospiraceae CAG; dark green CAG). Shown is the heatplot of the correlation values 
between OTUs detected at colonic mucosal surfaces. CAGs were defined on the basis of the clusters in the vertical or horizontal trees and named after 
their most notable characteristic. Column and row bars indicate bacterial CAGs (as per legend to the bottom right), fold change between individuals 
with CRC and healthy controls (as per legend to the bottom left) and bacterial CAGs determined with only the subset of 17 OTUs found both at 
colonic and oral mucosal surfaces (figure 3A). Legend top left: colour-scale correlation coefficient. (B) Scatterplot of the colonic prevalence of bacterial 
OTUs associated with oral pathogen and biofilm CAGs (figure 3A). Most OTUs were only detected on a subset of CRCs and polyps (circle) or healthy 
controls (triangle). CAGs, coabundance groups; CRCs, colorectal cancer; OTUs, operational taxonomic units.
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Figure 6 Similarity of non-neoplastic and neoplastic colonic disease associated bacterial profiles. (A) Shown is the heatplot of the correlation 
values between OTUs associated with rectal tissue of children with and without CD.21 CAGs were defined on the basis of the clusters in the vertical or 
horizontal trees and named after their most notable characteristic. Column and row bars indicate bacterial CAGs (as per legend to the bottom right), 
fold change between individuals with CD and healthy controls (as per legend to the bottom left). Additionally, two row and column bars indicate the 
CAG in the Irish CRC cohort (figure 4A) and the fold change between individuals with CRCs/polyps and healthy controls. Legend top left: colour scale 
correlation coefficient. (B) Venn diagram of bacteria found in colorectal tissue of children with CD, colorectal tumours and oral swabs. (C–E) Network 
plots of bacterial OTUs found in both the oral cavity and different colonic tissue samples: (C) tumours (ON; 65 individuals with CRC and 2 polyps), 
(D) mucosa from children with CD (n=201) and (E) mucosa from healthy children (n=122). For each group of samples, the OTUs shared with the oral 
cavity was determined separately. The size of each node (OTU) correlates to the mean abundance of each OTU across all samples in each respective 
sample group. The width of each edge corresponds to the p value of the correlation between each respective node (lower p value, higher line width). 
The location of each node was determined by a PCoA of the correlation distance as described in Materials and Methods. Only nodes with at least one 
significant edge are shown. Legend to the right: genus-level classification using RDP reference, version 14 of OTU representative sequences. CAGs, 
coabundance groups; CD, Crohn's disease; CRCs, colorectal cancer; OTUs, operational taxonomic units; PCoA, Principal Coordinates Analysis; RDP, 
Ribosomal Database Project.
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in faecal samples. Many of these bacterial taxa have previously 
been associated with oral biofilms. Together, these data suggest 
that oral-like biofilms also form on the mucosa of the colon. 
These bacteria were typically significantly more abundant on 
and off colorectal tumours as well as on and off colorectal polyps 
compared with the mucosa of healthy individuals and have been 
found to be associated with distinct mucosal gene expression 
profiles3 6 11 suggesting a role in the development or progres-
sion of CRC. The mucosal abundance of Lachnospiraceae CAG 
microbiota was significantly lower in individuals with CRC and 
was inversely associated with the presence (and abundance) 
of CRC-associated, oral-like bacterial OTUs, in both healthy 
individuals and individuals with CRC and colorectal polyps. 
Thus, we postulate that Lachnospiraceae CAG-type microbi-
otas prevent colonic colonisation with CRC-associated, oral-like 
bacterial biofilms.
The use of microbiome structure as a biomarker of health and 
disease is gaining momentum particularly with the development 
of affordable high-throughput DNA sequencing technology. It is 
now possible to obtain deep knowledge about the microbiota of 
a sample for less than $10 sequencing cost. Moreover, improved 
pipelines for in silico analysis of sequencing data enable 
researchers and clinicians to rapidly turn 16S rRNA amplicon 
sequencing data into clinically informative data without the 
need for dedicated large-scale computational facilities. Recent 
reports have shown the potential suitability of faecal microbiota 
profiles for screening for colonic lesions using 16S rRNA ampl-
icon sequencing,4 5 14 36 metagenomic sequencing5 and qPCR.14 
In addition, diagnostic tests may be improved with a combina-
tion of microbiota information and the FIT.4 5 The AUC values 
we obtained when using a combination of oral and faecal micro-
biota OTUs for CRC and adenoma detection (0.94 and 0.98, 
respectively) and the specificity (95% for both) and sensitivity 
(76% and 88%, respectively) were comparable or higher than 
those reported in the above-named studies (ranging from 0.64 
to 0.93), suggesting that the inclusion of oral microbiota infor-
mation has the potential to enhance the performance of current 
diagnostic tests. Particularly promising is the high sensitivity for 
the detection of adenomas (88%) because of the prognostic and 
therapeutic importance of early discovery of colonic disease. By 
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comparison, Baxter et al4 reported sensitivities below 20% for 
the detection of adenomas using either FIT or faecal microbiota 
composition alone and a sensitivity of below 40% when using 
a combination (specificity >90%). Our analysis significantly 
improves on this, and we were able to confirm the value of the 
oral microbiota to predict colonic lesions with an independent 
classification strategy employing both LASSO and RF feature 
selection. We concede, however, that larger prospective studies 
that account for potential confounders such as age, tumour 
stage, smoking and alcohol consumption and that combine FIT, 
faecal microbiota and oral microbiota composition are needed to 
verify these promising results.
Numerous reports have noted the enrichment of oral-type 
bacteria on colorectal tumours or in faeces of individuals with 
CRC or adenomas, particularly Fusobacterium, Peptostrepto-
coccus, Porphyromonas and Parvimonas,3–8 13 14 37 and the asso-
ciation of these bacteria with microscopic inflammation of the 
colonic mucosa.3 6 11 However, none of these studies included 
samples from the oral cavity, and direct comparisons were 
not possible. Dejea et al reported the association of bacterial 
biofilms with proximal CRCs38 but identified no single genus 
that was consistently associated with tumour biofilms, not even 
genus Fusobacterium, nor did they report differences in overall 
microbiota composition of biofilm-positive tumours compared 
with biofilm-negative tumours. Interestingly, members of the 
tumour-associated biofilm CAG that we report here (figure 3A) 
were indeed more prevalent and trended towards greater abun-
dance in the mucosa of proximal tumours. This sidedness was 
not detected in healthy individuals indicating that biological 
specificities of proximal cancers may be responsible.
Previous research indicated a secondary role of F. nucleatum, 
one of the oral bacterial OTUs also found in this study, in the 
development of CRC. F. nucleatum had no effect on the prolif-
eration on healthy colon epithelial cells11 and was reported to 
be enriched on colorectal lesions compared with paired healthy 
tissue of individuals with CRC,7 8 likely mediated by the over-
expression of Gal-GalNAc.39 These findings suggest a secondary 
involvement of F. nucleatum in the pathology of CRC. We also 
detected increased abundance of oral bacteria, including F. 
nucleatum at the site of the tumour, both compared with paired 
healthy tissue and healthy controls. However, the fact that we 
detect similar oral bacterial networks both off the tumour and in 
colonic mucosa of healthy controls makes it at least conceptually 
possible that such bacteria are indeed involved in the initiation 
of CRC and are both drivers and passengers of disease40 medi-
ated by thus far undiscovered mechanisms. Recently, Abed et al39 
showed that F. nucleatum enrichment is mediated through Fap2 
binding to Gal-GalNAc expressed on CRCs and suggested a 
hematogenous route for translocation of the bacterium from the 
oral cavity. In addition to F. nucleatum enrichment in individuals 
with CRCs or polyps, we also detected enrichment of the same 
bacterial OTU in paediatric CD. It has been shown that a subset of 
CD and ulcerative colitis subjects (9/20) express Gal-GalNAc.41 
It is thus tempting to speculate that a similar mechanism also 
leads to F. nucleatum enrichment in CD. However, although 
Gal-GalNAc was shown in one previous study to be expressed 
on 21 out of 25 of adenocarcinomas,41 we and others11 29 
detected F. nucleatum in 50% or less of CRCs, and high abun-
dance is found in only ~10% of CRCs.35 Thus, other mecha-
nisms apparently modulate the abundance of F. nucleatum at the 
site of CRC. The enrichment of similar oral bacterial networks 
in both CRC and CD (figure 6) may reflect general microbial 
community adaptation to a variable host response and it may be 
secondary in nature.
Our finding that the presence and abundance of oral pathogens 
both in CRC and in healthy individuals is negatively associated 
with the abundance of Lachnospiraceae such as Anaerostipes, 
Blautia and Roseburia suggests that these bacteria also play an 
important protective role. The concept that the gut microbiota 
protects against the colonisation of the bowel with environ-
mental bacteria, including pathogens, is well established42 and, 
according to our data, is also relevant in the context of CRC 
and CD. Moreover, the association we report here between the 
abundance of Lachnospiraceae and a healthy diet points to a 
new thread in the recognised diet–microbiota–disease paradigm, 
specifically in the concept of CRC, and provides further ratio-
nale for promoting a healthy diet to limit lifelong risk of this 
disease.
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